Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
Clinical trial NCT02718716 · COMPLETED
Trial details
- NCT number
- NCT02718716
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-02
- Primary completion
- 2019-02-04
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.